Haemonetics Corp
HAE
Revenue
336.17M
▼-7.12M▼-2.07%
3 Months ChangeAssets
2.54B
▲345.39M▲15.73%
3 Months ChangeLiabilities
1.64B
▲399.98M▲32.37%
3 Months ChangeFree Cash Flow
-33.08M
▼-44.48M▼-390.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0000313143-24-000056
2024-08-08
Form 10-Q
ID: 0000313143-24-000054
2024-08-08
Form 8-K
ID: 0000313143-24-000053
2024-07-25
Form 8-K
ID: 0000313143-24-000044
2024-05-29
Form 8-K
ID: 0001104659-24-066056
2024-05-23
Form 8-K
ID: 0001104659-24-064437
2024-05-21
Form 8-K
ID: 0001104659-24-063835
2024-05-09
Form 8-K
ID: 0000313143-24-000015
2024-05-01
Form 8-K
ID: 0000950103-24-006128
2024-04-01
Form 8-K
ID: 0000313143-24-000012